Home   >    Proteins   >   Protein Kinases

PFTK1 (CDK14), Unactive

Recombinant full-length human PFTK1 (CDK14) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Catalog No. P15-30G




Catalog No. Pack Size Price (USD)
P15-30G-20 20 ug $215
P15-30G-50 50 ug $435
P15-30G-BULK BULK Contact Us  


Overview:

PFTK1, also known as PFTAIRE protein kinase 1, is a member of the CDC2 -related protein kinase family which is expressed primarily in the postnatal and adult nervous system (1). PFTK1 is highly expressed in brain, pancreas, kidney, heart, testis, and ovary. PFTK1 interacts with 14-3-3-beta, 14-3-3-epsilon, 14-3-3-eta and 14-3-3-tau. Using PFTK1 mutant constructs and in vitro and in vivo binding studies, it was shown that PFTK1 amino acid residue ser119 is required for its interaction with all four 14-3-3 isoforms. (2). Significant upregulation of PFTK1 expression is observed in oesophageal squamous cell carcinoma (ESCC). PFTK1 is not only useful as a prognostic marker in ESCC, but also as a predictor of the response to chemotherapy.


Gene Aliases:

CDK14; PFTAIRE1


Genbank Number:


References:


1. Yang, T.et.al: Identification and cellular localization of human PFTAIRE1. Gene 267: 165-172, 2001.

2. Gao, Y. et.al: A Cdc2-related protein kinase hPFTAIRE1 from human brain interacting with 14-3-3 proteins. Cell Res. 16: 539-547, 2006.


Purity:

Sample Purity Data. For specific information on a given lot, see related technical data sheet.


Storage, Stability and Shipping:

Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.


Molecular Weight:

~72 kDa



Product Datasheets



PRODUCT RESOURCES
RESEARCH AREAS

Cancer, Cell Cycle, Ser/Thr Kinases


RELATED PRODUCTS


  PFTK1 (CDK14)/CyclinY, Active, P15-10G

  RIPK1, Active, R07D-112G


SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox